Digital Health Global
MAY 8, 2023
(NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.
Digital Health Global
APRIL 25, 2024
Locally advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are typically treated with definitive thoracic radiotherapy (RT), often in the form of concurrent chemoradiotherapy (CRT). Lung cancer is the leading cause of cancer mortality in the United States and worldwide.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
MARCH 14, 2023
Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by Country. Industry Participants 4.2
Society for Participatory Medicine
JANUARY 27, 2022
Let’s look back even further to 2013 to examine one definition of patient engagement: Health Affairs defines patient engagement as combining patient activation with interventions designed to increase and promote positive patient behavior, such as obtaining preventive care or exercising regularly, hopefully to lower costs.
Health Populi
FEBRUARY 5, 2023
Were GWI to re-calibrate this landscape today, post-pandemic, I would guestimate that the mental wellness bubble would be much larger, with personal care and beauty definitely bolstered in and in the wake of the pandemic. Being Missourian in spirit and intent: seeking the science and the evidence.
Digital Health Global
APRIL 5, 2024
Guide for Investment Analysts and Management Consultants 2 Introduction and Market Definition 2.1 Market Definition 2.5 ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 Key Topics Covered: 1 Market Guides 1.1 Situation Analysis 1.2 Guide for Executives and Marketing Staff 1.3
Healthcare IT Today
JANUARY 8, 2024
Streamlining Due Diligence with AI: AI technologies will likely be crucial in conducting efficient and thorough due diligence, examining potential M&A targets in the biotech industry for their scientific innovation, financial stability, and market compatibility. Dave Latshaw, CEO at BioPhy 1.
Expert insights. Personalized for you.
88 
Let's personalize your content